Related Experiment Videos
Sturge-Weber syndrome: a review
Kristin A Thomas-Sohl1, Dale F Vaslow, Bernard L Maria
1Department of Child Health, University of Missouri-Columbia, Missouri, USA.
Pediatric Neurology
|May 29, 2004
Summary
Sturge-Weber syndrome is a rare neurological disorder affecting about 1 in 50,000 people. This review covers its key features, variable clinical course, and best management strategies.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Sturge-Weber syndrome (SWS) is a rare congenital disorder characterized by a facial vascular malformation (port-wine stain) and abnormalities in the brain and eyes.
- It involves leptomeningeal angiomatosis, typically affecting the occipital and posterior parietal lobes, leading to neurological complications.
- The syndrome occurs sporadically with an estimated frequency of 1 in 50,000 births.
Purpose of the Study:
- To provide a comprehensive overview of Sturge-Weber syndrome.
- To detail the characteristic clinical features, including vascular malformations, neurological deficits, and ophthalmologic issues.
- To discuss the variable clinical course and outline optimal management strategies.
Main Methods:
- This is a review article, synthesizing existing literature on Sturge-Weber syndrome.
- Information was gathered from published studies, case reports, and clinical guidelines.
- The review focuses on characteristic features, pathophysiology, clinical manifestations, and treatment approaches.
Main Results:
- Sturge-Weber syndrome presents with a wide spectrum of clinical severity.
- Common manifestations include facial port-wine stains, seizures, glaucoma, and developmental delays.
- Intracranial vascular anomalies can lead to ischemia, calcification, and cortical necrosis, resulting in neurological deficits and strokelike episodes.
Conclusions:
- Sturge-Weber syndrome requires a multidisciplinary approach for optimal management.
- Early diagnosis and intervention are crucial for managing symptoms and improving outcomes.
- Ongoing research is needed to better understand the pathophysiology and develop targeted therapies.